The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: Preempting a problem

Transfusion

Volumn 52, Issue 9, 2012, Pages 1931-1939

  Kitchen, Alan D ^a,b,c   Hewitt, Patricia E ^a,b,c   Chiodini, Peter L ^a,b,c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b Hospital for Tropical Diseases   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOON ANTIBODY;

ARTICLE; ASSAY; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH PROGRAM; HUMAN; NONHUMAN; PARASITE TRANSMISSION; PRACTICE GUIDELINE; RISK ASSESSMENT; SCREENING; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA CRUZI; UNITED KINGDOM;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; BLOOD DONORS; BLOOD TRANSFUSION; CHAGAS DISEASE; DONOR SELECTION; EARLY MEDICAL INTERVENTION; ENGLAND; FEMALE; HEALTH PLAN IMPLEMENTATION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; SEROLOGIC TESTS; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 84865728555     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03599.x     Document Type: Article

References (28)

1. World Health Organization. Chagas disease (American trypanosomiasis). World Health Organization fact sheet N°340 June 2010.
2. Prata A,. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001; 2: 92-100.
3. Schmunis GA,. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007; 102 Suppl I: 75-85.
4. Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, Dodd RY,. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in U.S. blood donors. J Infect Dis 1997; 176: 1047-52.
5. El Ghouzzi M-H, Boiret E, Wind F, Brochard C, Fittere S, Paris L, Mazier D, Sansonetti N, Bierling P,. Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening. Transfusion 2010; 50: 575-83.
6. Piron M, Verges M, Munoz J, Casamitjana N, Sanz S, Maymõ RM, Hernández JM, Puig L, Portús M, Gascõn J, Sauleda S,. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 2008; 48: 1862-8.
7. Jackson Y, Angheben A, Carrilero Fernandez B, Jansa i Lopez del Vallado JM, Jannin JG, Albajar-Viñas P,. Management of Chagas disease in Europe. Experiences and challenges in Spain, Switzerland and Italy. "Bulletin de la Société de pathologie exotique (1990). Bull Soc Pathol Exot 2009 Dec; 102 (5): 326-9. lsqb;Correction statement added after online publication 13-March-2012. The reference has been updated.rsqb
8. Gascon J, Bern C, Pinazo MJ,. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 2010; 115: 22-7.
9. Young C, Losikoff P, Chawla A, Glasser L, Forman E,. Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007; 47: 540-4.
10. Cimo P, Luper W, Scouros M,. Transfusion-associated Chagas' disease in Texas: report of a case. Texas Med 1993; 89: 48-50.
11. Herwaldt BL, Grijalva MJ, Newsome AL, McGhee CR, Powell MR, Nemec DG, Steurer FJ, Eberhard ML,. Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypoanosoma cruzi, in Tennessee. J Infect Dis 2000; 181: 395-9.
12. Wendel S,. Transfusion transmitted Chagas disease: is it really under control? Acta Trop 2010; 115: 28-34.
13. Schmunis GA,. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991; 31: 547-57.
14. Wendel S,. Transfusion-transmitted Chagas' disease. Cur Opin Hem 1998; 5: 406-11.
15. Castro E,. Chagas disease: lessons from routine donation testing. Transfus Med 2009; 19: 16-23.
16. Leiby DA, Herron RM Jr., Read EJ, Lenes BA, Stumpf RJ,. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 42: 549-55.
17. Jackson Y, Gétaz L, Wolff H, Holst M, Mauris A, Tardin A, Sztajzel J, Besse V, Loutan L, Gaspoz J-M, Jannin J, Vinas P-A, Luquetti A, Chappuis F,. Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis 2010; 4: e592.
18. Malan AK, Avelar E, Litwin SE, Hill HR, Litwin CM,. Serological diagnosis of Trypanosoma cruzi: evaluation of three enzyme immunoassays and an indirect immunofluorescent assay. J Med Microbiol 2006; 55: 171-8.
19. Remesar MC, Gamba C, Colaianni IF, Puppo M, Sartor PA, Murphy EL, Neilands EB, Ridolfi MA, Leguizamõn MS, Kuperman S, del Pozo AE,. Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina. Transfusion 2009; 49: 2352-8.
20. Otani MM, Vinelli E, Kirchhoff LV, Ana del Pozo A, Sands A, Vercauteren G, Sabino EC,. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion 2009; 49: 1076-82.
21. Agapova M, Busch MP, Custer B,. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion 2010; 50: 2220-32.
22. Basile L, Jansà JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, Seixas J, Van Gool T, Cañavate C, Flores-Chávez M, Jackson Y, Chiodini PL, Albajar-Viñas P,. Working Group on Chagas Disease. Chagas disease in European countries: the challenge of a surveillance system. Eurosurveillance 2011; 16:pii-19968.
23. Serious Hazards of Transfusion Steering Committee. Serious hazards of transfusion: annual report 2010. Manchester (UK): SHOT Office; 2011. [cited 2012 Feb 21]. Available from: URL: http://www.shotuk.org/wp-content/uploads/2011/10/ SHOT-2010-Report1.pdf
24. World Health Organization. Control and prevention of Chagas disease in Europe. Report of a WHO informal consultation; 17-18 December 2009. WHO/HTM/NTD/IDM/2010.1. 2010. [cited 2012 Feb 21]. Available from: URL: http://www.fac.org.ar/1/comites/chagas/Chagas-WHO-Technical%20Report-16-06-10. pdf
25. UK Blood Transfusion & Tissue Transplantation Services. Guidelines for the Blood Transfusion Services in the UK. 2005. [cited 2012 Feb 21]. Available from: URL: http://www.transfusionguidelines.org.uk/index.aspx? Publication=RB
26. Umezawa ES, Nascimento MS, Kesper N Jr., Coura JR, Borges-Pereira J, Junqueira AC, Camargo ME,. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas disease. J Clin Microbiol 1996; 34: 2143-7.
27. Castro E, Gironés N, Bueno JL, Carriõn J, Lin L, Fresno M,. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion 2007; 47: 434-41.
28. Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R,. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 2007; 37: 131-7.